Sage Therapeutics (SAGE) 324 Data is Positive but More Detail on Side Effects is Needed - Mizuho Securities
Go back to Sage Therapeutics (SAGE) 324 Data is Positive but More Detail on Side Effects is Needed - Mizuho SecuritiesBIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 214.95 -1.39 (0.64%) | |||||
---|---|---|---|---|---|---|
Previous Close | $216.34 | 52 Week High | $333.65 | |||
Open | $217.36 | 52 Week Low | $223.02 | |||
Day High | $217.57 | P/E | 27.52 | |||
Day Low | $214.82 | EPS | $7.81 | |||
Volume | 88,187 |
Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 18.60 -0.44 (2.31%) | |||||
---|---|---|---|---|---|---|
Previous Close | $19.04 | 52 Week High | $62.64 | |||
Open | $19.06 | 52 Week Low | $26.28 | |||
Day High | $19.34 | P/E | N/A | |||
Day Low | $18.51 | EPS | $-0.94 | |||
Volume | 65,061 |